1 Day
Source:
مأرب برس
مأرب برس
Ready to play
Ready to play
Reports indicate that Pfizer plans to launch a new COVID-19 vaccine in global markets by 2026, following their recent release of 43 different vaccines across various regions. The companies are aiming to develop several types of vaccines, including single-dose, booster, and emergency versions, to enhance protection and reduce symptoms. Experts anticipate that preliminary data will show high efficacy for the new vaccines, with expectations that they will contribute to lowering infection and death rates associated with the virus in the coming years.
Notice: This Is an AI-Generated Summary
Comments (0)